Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05190016Completed

Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19

Role: lead

NCT05150509Unknown

Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy

Role: lead

NCT04549376Phase 2Completed

Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo

Role: lead

NCT04872686Phase 3Completed

Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx

Role: lead

All 4 trials loaded